Clinical Trial Update: Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether twice-daily rabeprazole improves asthma control in subjects with asthma, with GERD as a co-occurring condition; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Gastroesophageal Reflux Disease

Drugs mentioned

• ACIPHEX (rabeprazole sodium)
• Rabeprazole (rabeprazole)

Snippet

Sponsor: Associated Scientists to Help Minimize Allergies | Conditions: Asthma, Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED